AR038373A1 - Sistema de suministro osmotico - Google Patents
Sistema de suministro osmoticoInfo
- Publication number
- AR038373A1 AR038373A1 ARP030100272A ARP030100272A AR038373A1 AR 038373 A1 AR038373 A1 AR 038373A1 AR P030100272 A ARP030100272 A AR P030100272A AR P030100272 A ARP030100272 A AR P030100272A AR 038373 A1 AR038373 A1 AR 038373A1
- Authority
- AR
- Argentina
- Prior art keywords
- osmotic
- supply system
- single layer
- weight
- osmotic supply
- Prior art date
Links
- 230000003204 osmotic effect Effects 0.000 title abstract 2
- 239000002356 single layer Substances 0.000 abstract 2
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 abstract 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 abstract 1
- 239000010410 layer Substances 0.000 abstract 1
- 239000002357 osmotic agent Substances 0.000 abstract 1
- 230000005070 ripening Effects 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Se describe un comprimido farmacéutico osmótico que comprende un núcleo comprimido de capa sencilla rodeado por una capa permeable al agua que tiene un paso. El núcleo de capa sencilla contiene (i) un fármaco no madurador con una solubilidad por dosis menor que aproximadamente 1ml-1, (ii) aproximadamente 2,0% a aproximadamente 20% en peso de una hidroxietilcelulosa con un peso molecular medio ponderal de aproximadamente 300.000 a aproximadamente 2.000.000 y (iii) un agente osmótico.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35315102P | 2002-02-01 | 2002-02-01 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR038373A1 true AR038373A1 (es) | 2005-01-12 |
Family
ID=27663182
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP030100272A AR038373A1 (es) | 2002-02-01 | 2003-01-30 | Sistema de suministro osmotico |
Country Status (23)
Country | Link |
---|---|
US (1) | US20030175346A1 (es) |
EP (1) | EP1469826B1 (es) |
JP (1) | JP2005518418A (es) |
KR (1) | KR20040083492A (es) |
CN (1) | CN1625388A (es) |
AR (1) | AR038373A1 (es) |
AT (1) | ATE345776T1 (es) |
BR (1) | BR0307320A (es) |
CA (1) | CA2474425A1 (es) |
DE (1) | DE60309832T2 (es) |
ES (1) | ES2277632T3 (es) |
GT (1) | GT200300017A (es) |
MX (1) | MXPA04007437A (es) |
NO (1) | NO20043646L (es) |
NZ (1) | NZ533986A (es) |
PA (1) | PA8565201A1 (es) |
PE (1) | PE20030801A1 (es) |
PL (1) | PL372172A1 (es) |
RU (1) | RU2004123623A (es) |
TW (1) | TW200302748A (es) |
UY (1) | UY27644A1 (es) |
WO (1) | WO2003063823A2 (es) |
ZA (1) | ZA200405406B (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0203296D0 (en) | 2002-02-12 | 2002-03-27 | Glaxo Group Ltd | Novel composition |
US8637512B2 (en) | 2002-07-29 | 2014-01-28 | Glaxo Group Limited | Formulations and method of treatment |
US7829507B2 (en) * | 2003-09-17 | 2010-11-09 | Halliburton Energy Services Inc. | Subterranean treatment fluids comprising a degradable bridging agent and methods of treating subterranean formations |
MX2007006199A (es) * | 2004-11-24 | 2007-07-13 | Teva Pharma | Composiciones de desintegracion oral de rasagilina. |
GB2421431B (en) * | 2004-12-24 | 2007-10-10 | Aquasol Ltd | Dosing systems |
WO2006072878A1 (en) * | 2005-01-07 | 2006-07-13 | Ranbaxy Laboratories Limited | Oral dosage forms of sertraline having controlled particle size and processes for their preparation |
DE102005009240A1 (de) * | 2005-03-01 | 2006-09-07 | Bayer Healthcare Ag | Arzneiformen mit verbesserten pharmakokinetischen Eigenschaften |
US8637080B2 (en) | 2007-06-28 | 2014-01-28 | Osmotica Kereskedelmi és Szolgáltató, KFT | Rupturing controlled release device comprising a subcoat |
CA2757979A1 (en) * | 2009-04-09 | 2010-10-14 | Alkermes Pharma Ireland Limited | Controlled-release clozapine compositions |
AU2010260208B2 (en) | 2009-06-16 | 2014-11-13 | Bristol-Myers Squibb Holdings Ireland Unlimited Company | Dosage forms of apixaban |
IT1399240B1 (it) * | 2010-03-22 | 2013-04-11 | Trere Chimica S A S | Metodo e prodotto per il trattamento di sostanze alcooliche, mosti d'uva e derivati |
CN102379858B (zh) * | 2011-10-12 | 2013-06-19 | 中国药科大学 | 一种可装载大剂量难溶性药物并促进其吸收的渗透泵片 |
JP6041823B2 (ja) | 2013-03-16 | 2016-12-14 | ファイザー・インク | トファシチニブの経口持続放出剤形 |
Family Cites Families (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US143272A (en) * | 1873-09-30 | Improvement in saw-sets | ||
US64556A (en) * | 1867-05-07 | Improved belt-punch | ||
US39691A (en) * | 1863-08-25 | Improvement in pipe-couplings | ||
US3845770A (en) * | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
US3916899A (en) * | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
US4036228A (en) * | 1975-09-11 | 1977-07-19 | Alza Corporation | Osmotic dispenser with gas generating means |
US4077407A (en) * | 1975-11-24 | 1978-03-07 | Alza Corporation | Osmotic devices having composite walls |
US4111202A (en) * | 1976-11-22 | 1978-09-05 | Alza Corporation | Osmotic system for the controlled and delivery of agent over time |
US4265874A (en) * | 1980-04-25 | 1981-05-05 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
US4327725A (en) * | 1980-11-25 | 1982-05-04 | Alza Corporation | Osmotic device with hydrogel driving member |
US4627850A (en) * | 1983-11-02 | 1986-12-09 | Alza Corporation | Osmotic capsule |
US4610686A (en) * | 1983-11-02 | 1986-09-09 | Alza Corporation | Controlled delivery of haloperidol by an osmotic delivery system |
US4732915A (en) * | 1983-11-02 | 1988-03-22 | Alza Corporation | Process for increasing solubility of drug |
US4627971A (en) * | 1985-04-22 | 1986-12-09 | Alza Corporation | Osmotic device with self-sealing passageway |
CH668187A5 (de) * | 1986-08-07 | 1988-12-15 | Ciba Geigy Ag | Therapeutisches system mit systemischer wirkung. |
US5108756A (en) * | 1989-01-12 | 1992-04-28 | Pfizer Inc. | Dispensing devices powered by lyotropic liquid crystals |
US5071607A (en) * | 1990-01-31 | 1991-12-10 | Alza Corporatino | Method and apparatus for forming a hole in a drug dispensing device |
US5284662A (en) * | 1990-10-01 | 1994-02-08 | Ciba-Geigy Corp. | Oral osmotic system for slightly soluble active agents |
US5869097A (en) * | 1992-11-02 | 1999-02-09 | Alza Corporation | Method of therapy comprising an osmotic caplet |
HU213407B (en) * | 1993-12-09 | 1997-06-30 | Egyt Gyogyszervegyeszeti Gyar | Process for producing tablet with diffusive-osmotic release |
US5698224A (en) * | 1994-06-27 | 1997-12-16 | Alza Corporation | Tacrine therapy |
US5736159A (en) * | 1995-04-28 | 1998-04-07 | Andrx Pharmaceuticals, Inc. | Controlled release formulation for water insoluble drugs in which a passageway is formed in situ |
US5654005A (en) * | 1995-06-07 | 1997-08-05 | Andrx Pharmaceuticals, Inc. | Controlled release formulation having a preformed passageway |
ES2255103T3 (es) * | 1996-10-25 | 2006-06-16 | Shire Laboratories Inc. | Sistema osmotico de administracion de dosis en forma soluble. |
US6361796B1 (en) * | 1996-10-25 | 2002-03-26 | Shire Laboratories, Inc. | Soluble form osmotic dose delivery system |
US5837379A (en) * | 1997-01-31 | 1998-11-17 | Andrx Pharmaceuticals, Inc. | Once daily pharmaceutical tablet having a unitary core |
US6485748B1 (en) * | 1997-12-12 | 2002-11-26 | Andrx Pharmaceuticals, Inc. | Once daily pharmaceutical tablet having a unitary core |
US6224907B1 (en) * | 1998-03-06 | 2001-05-01 | Alza Corporation | Anti-asthma therapy |
US6099859A (en) * | 1998-03-20 | 2000-08-08 | Andrx Pharmaceuticals, Inc. | Controlled release oral tablet having a unitary core |
US6156342A (en) * | 1998-05-26 | 2000-12-05 | Andex Pharmaceuticals, Inc. | Controlled release oral dosage form |
US20010031279A1 (en) * | 1998-11-02 | 2001-10-18 | Evangeline Cruz | Controlled delivery of antidepressants |
JP2000171868A (ja) * | 1998-12-08 | 2000-06-23 | Canon Inc | フィルム送り装置、フィルム使用装置および光学機器 |
US6706283B1 (en) * | 1999-02-10 | 2004-03-16 | Pfizer Inc | Controlled release by extrusion of solid amorphous dispersions of drugs |
US6352721B1 (en) * | 2000-01-14 | 2002-03-05 | Osmotica Corp. | Combined diffusion/osmotic pumping drug delivery system |
AR026148A1 (es) * | 2000-01-21 | 2003-01-29 | Osmotica Argentina S A | Dispositivo osmotico con pasaje preformado que aumenta de tamano |
WO2001091716A1 (en) * | 2000-05-30 | 2001-12-06 | Add Advanced Drug Delivery Technologies Ag | Peroral therapeutic system comprising glipizide |
IN190699B (es) * | 2001-02-02 | 2003-08-16 | Sun Pharmaceutical Ind Ltd | |
US20030185882A1 (en) * | 2001-11-06 | 2003-10-02 | Vergez Juan A. | Pharmaceutical compositions containing oxybutynin |
-
2003
- 2003-01-27 TW TW092101714A patent/TW200302748A/zh unknown
- 2003-01-27 US US10/352,283 patent/US20030175346A1/en not_active Abandoned
- 2003-01-28 PL PL03372172A patent/PL372172A1/xx unknown
- 2003-01-28 EP EP03701640A patent/EP1469826B1/en not_active Expired - Lifetime
- 2003-01-28 CA CA002474425A patent/CA2474425A1/en not_active Abandoned
- 2003-01-28 KR KR10-2004-7011821A patent/KR20040083492A/ko active IP Right Grant
- 2003-01-28 NZ NZ533986A patent/NZ533986A/xx unknown
- 2003-01-28 AT AT03701640T patent/ATE345776T1/de not_active IP Right Cessation
- 2003-01-28 WO PCT/IB2003/000265 patent/WO2003063823A2/en active IP Right Grant
- 2003-01-28 CN CNA038031213A patent/CN1625388A/zh active Pending
- 2003-01-28 MX MXPA04007437A patent/MXPA04007437A/es unknown
- 2003-01-28 BR BR0307320-3A patent/BR0307320A/pt not_active IP Right Cessation
- 2003-01-28 ES ES03701640T patent/ES2277632T3/es not_active Expired - Lifetime
- 2003-01-28 RU RU2004123623/15A patent/RU2004123623A/ru not_active Application Discontinuation
- 2003-01-28 JP JP2003563517A patent/JP2005518418A/ja not_active Abandoned
- 2003-01-28 DE DE60309832T patent/DE60309832T2/de not_active Expired - Lifetime
- 2003-01-29 GT GT200300017A patent/GT200300017A/es unknown
- 2003-01-30 PE PE2003000100A patent/PE20030801A1/es not_active Application Discontinuation
- 2003-01-30 AR ARP030100272A patent/AR038373A1/es unknown
- 2003-01-31 UY UY27644A patent/UY27644A1/es not_active Application Discontinuation
- 2003-02-03 PA PA20038565201A patent/PA8565201A1/es unknown
-
2004
- 2004-07-07 ZA ZA200405406A patent/ZA200405406B/en unknown
- 2004-08-31 NO NO20043646A patent/NO20043646L/no unknown
Also Published As
Publication number | Publication date |
---|---|
RU2004123623A (ru) | 2005-04-20 |
ZA200405406B (en) | 2005-07-07 |
WO2003063823A3 (en) | 2003-12-04 |
MXPA04007437A (es) | 2004-10-11 |
ES2277632T3 (es) | 2007-07-16 |
DE60309832D1 (de) | 2007-01-04 |
WO2003063823A2 (en) | 2003-08-07 |
CN1625388A (zh) | 2005-06-08 |
CA2474425A1 (en) | 2003-08-07 |
EP1469826B1 (en) | 2006-11-22 |
US20030175346A1 (en) | 2003-09-18 |
UY27644A1 (es) | 2003-09-30 |
BR0307320A (pt) | 2004-12-28 |
NZ533986A (en) | 2006-03-31 |
GT200300017A (es) | 2003-09-22 |
PE20030801A1 (es) | 2003-09-19 |
DE60309832T2 (de) | 2007-10-11 |
TW200302748A (en) | 2003-08-16 |
JP2005518418A (ja) | 2005-06-23 |
ATE345776T1 (de) | 2006-12-15 |
PL372172A1 (en) | 2005-07-11 |
KR20040083492A (ko) | 2004-10-02 |
PA8565201A1 (es) | 2003-12-10 |
NO20043646L (no) | 2004-08-31 |
EP1469826A2 (en) | 2004-10-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR038373A1 (es) | Sistema de suministro osmotico | |
SV2002000250A (es) | Formula de dosis de droga accionada por hidrogel ref. pc10818ajtb/bb | |
UY25055A1 (es) | Formulaciones farmacéuticas que contienen voriconazol | |
AR012927A1 (es) | Una composicion farmaceutica, una forma de dosificacion farmaceutica, el uso de dicha composicion para la fabricacion de un medicamento y una forma depresentacion farmaceutica adecuada para la venta comercial | |
PA8575701A1 (es) | Preparaciones acidas de insulina con estabilidad mejorada | |
DE60310039D1 (de) | Pharmazeutische tablette | |
BR0015605A (pt) | Composição e uso | |
PE20001058A1 (es) | Sistema de entrega controlado de droga administrado oralmente, que provee control temporal y espacial | |
AR065073A2 (es) | Una formulacion medicamentosa de sistema de matriz que tiene liberacion controlada de un compuesto activo | |
UY27682A1 (es) | Composiciones farmacéuticas | |
UY25544A1 (es) | Forma de dosificación de nefazodona | |
DK0998916T3 (da) | Lægemidler til administration til slimhinden | |
DE60235648D1 (de) | Pharmazeutische metformintablette mit verlängerter freisetzung | |
AR014012A1 (es) | Formula de liberacion prolongada | |
AR026968A1 (es) | Una tableta matriz que permite la liberacion prolongada de trimetazidina lluego de su administracion por via oral | |
AR029509A1 (es) | Una composicion farmaceutica en base a un compuesto de platino (iv) y el uso de dicho compuesto para preparar medicamentos antitumorales | |
PE20030830A1 (es) | Ambroxol para el tratamiento de estados dolorosos en la cavidad bucal y faringea | |
ES2171459T3 (es) | Polvo para administracion nasal de farmaco peptidico o proteinaceo. | |
AR043536A1 (es) | Composicion farmaceutica que comprende acido 5-metil-2-(2´-cloro-6´-fluoroanilino)fenilacetico | |
AR004196A1 (es) | Un metodo a alta velocidad para preparar granulos esfericos que comprende un medicamento para uso farmaceutico, granulos obtenibles mediante este metodoy una bolsita que contiene dichos granulos | |
AR014881A1 (es) | Uso de un sensibilizador a insulina y un agente antihiperglucemico para la preparacion de un medicamento y composicion farmaceutica que comprendedicho sensibilizador y dicho agente | |
SE0001071D0 (sv) | Method of inhibiting the expression of inflammatory cytokines and chemokines | |
ATE256134T1 (de) | Sulfatierte phosphatidylinositole, ihre herstellung und verwendung | |
DE60112578D1 (de) | Pharmazeutische diclofenac-verbindung basierend auf vitamin e, papain und hyaluronidase | |
GT200000187A (es) | Un estuche de combinacion usado en el tratamiento del paludismo. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |